Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
Targeting the Accomplices of MYC in MYC-driven Medulloblastoma |
Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D. |
Innovation Grants |
2014 |
California |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells |
Stanford University School of Medicine / Alice Bertaina, MD/PhD |
Reach Grants |
2019 |
California |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children’s Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma |
University of California San Francisco / William Weiss, MD/PhD |
Innovation Grants |
2018 |
California |
The Identification of Neuroblastoma Cancer Stem Cells.
|
Stanford University / Robert Cho |
Young Investigator Grants |
2007 |
California |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2012 |
California |